Rite Aid inks deal with Save-A-Lot
CAMP HILL, Pa. Rite Aid has entered a licensing agreement with Save-A-Lot stores to bring the grocer’s discount, limited assortment concept to 10 existing Rite Aid locations in the Greenville, S.C., market.
The stores will be co-branded Save-A-Lot Food Stores/Rite Aid Pharmacy and will continue to be owned and operated by Rite Aid, the drug store chain said. The store test is part of Rite Aid’s segmentation strategy, which was implemented in early 2009, and seeks to identify unique opportunities among like groups of stores.
The ten stores, which are located in Greenville, Easley, Greer, Simpsonville and Travelers Rest, will remain open as they begin converting to the new format this month. Rite Aid said it has designed the remodel process to make sure the pharmacy remains easily accessible, and Rite Aid’s pharmacy teams can continue to offer the same high level of service Greenville residents have come to expect. The remodels are expected to be completed in October.
The locations of the stores are:
- 5991 Calhoun Memorial Highway, Easley
- 1400 Woodruff Rd., Greenville
- 1 East Stone Ave., Greenville
- 6700 Whitehorse Rd., Greenville
- 3050 Whitehorse Rd., Greenville
- 2422 Wade Hampton Blvd., Greenville
- 1100 West Wade Hampton Blvd., Greer
- 930 North East Main St., Simpsonville
- 202 Scuffletown Rd., Simpsonville
- 6414 State Park Rd., Travelers Rest.
“We believe this new co-branded concept meets the needs of today’s consumers, who continue to search for value, quality and convenience, and we’re excited about the chance to offer our customers high-quality grocery products, including fresh meats and farm-fresh produce at great prices,” said Ken Martindale, Rite Aid COO. “We chose to add Save-A-Lot because of its strong sales record, wide selection of attractively priced exclusive brands and its solid reputation for discount grocery. Plus, it’s a model that’s efficient for Rite Aid associates to operate.”
CPSC, Health Canada find no link between Pampers Dry Max and diaper rash
CINCINNATI The U.S. Consumer Product Safety Commission and Health Canada announced Friday that they have found no cause linking Pampers Dry Max diapers and reports of diaper rash and other skin conditions.
"We are thankful that the U.S. CPSC and Health Canada conducted their thorough reviews and have not identified any cause for concern with Pampers with Dry Max," said Jodi Allen, VP of Pampers. "Our heartfelt mission is always to care for and protect babies, and, as such, safety is, and will always be, our No. 1 priority. We hope that today’s announcement will reassure the millions of moms, dads and child caregivers who place their trust in Pampers and Dry Max every day. We thank our customers for their continued support and greatly value and appreciate the trust they place in us."
To help parents battle diaper rash, Pampers is sponsoring the distribution of comprehensive educational materials produced by the American Academy of Pediatrics that provide detailed information on the care and treatment of infant skin conditions, including diaper rash, according to Allen. The AAP materials are available as free brochures and will appear in the summer issue of AAP Healthy Children Magazine, as well as online at HealthyChildren.org and at Pampers.com.
Pfizer ends brain cancer drug development deal with Celldex
NEEDHAM, Mass. Pfizer is pulling out of a development deal for a potential brain cancer drug, saying it is not a strategic priority, according to the drug’s developer Celldex Therapeutics.
Celldex said it will regain full worldwide rights to develop and sell rindopepimut from Pfizer. The drug candidate also is called CDX-110. In May, the company reported positive results form a midstage study on the drug.
Celldex will regain rights to the drug candidate on Nov. 1.